Literature DB >> 10359139

Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization.

H Oka1, T Kameya, Y Sato, H Naritaka, N Kawano.   

Abstract

This study examined the expression of human growth hormone-releasing hormone receptor (GHRH-R) mRNA in both non-neoplastic pituitary tissues and pituitary adenomas by reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization (ISH). RT-PCR analysis showed that all of the non-neoplastic pituitaries and all GH-producing adenomas, one prolactinoma and one third of the non-functioning adenomas expressed GHRH-R mRNA. ISH demonstrated that all of GH-producing adenomas and two prolactinomas expressed GHRH-R mRNA. The expression of GHRH-R mRNA in GH-producing adenomas was greater than that in the other adenomas by RT-PCR and ISH. GHRH-R mRNA detected by ISH was observed only in GH cells from the pituitary gland of a young girl. In pituitary adenomas, a diffuse signal was observed in the cytoplasm of all of the GH-producing adenomas and in two prolactinomas. Expression of GHRH-R mRNA was not seen in normal prolactin cells, or in any adenomas other than GH-producing adenomas and a few prolactinomas. These results suggest that GHRH-R mRNA plays a role mainly in the function of GH-producing adenomas but may also play a role in function of some prolactinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359139     DOI: 10.1023/a:1006151001536

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization histochemistry.

Authors:  S Hirota; A Ito; E Morii; A Wanaka; M Tohyama; Y Kitamura; S Nomura
Journal:  Brain Res Mol Brain Res       Date:  1992-09

2.  Relationship of plasma growth hormone-releasing hormone levels to pubertal changes.

Authors:  J Argente; D Evain-Brion; A Munoz-Villa; P Garnier; M Hernandez; M Donnadieu
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

3.  Covalent cross-linking of growth hormone-releasing factor to pituitary receptors.

Authors:  G Veliçelebi; S Patthi; S Provow; M Akong
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

4.  Binding sites for growth hormone releasing factor on rat anterior pituitary cells.

Authors:  H Seifert; M Perrin; J Rivier; W Vale
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

5.  Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro.

Authors:  N Billestrup; L W Swanson; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle.

Authors:  W S Evans; J L Borges; M L Vance; D L Kaiser; A D Rogol; R Furlanetto; J Rivier; W Vale; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1984-11       Impact factor: 5.958

7.  Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients.

Authors:  M O Thorner; L A Frohman; D A Leong; J Thominet; T Downs; P Hellmann; J Chitwood; J M Vaughan; W Vale
Journal:  J Clin Endocrinol Metab       Date:  1984-11       Impact factor: 5.958

Review 8.  Etiology of pituitary acromegaly.

Authors:  S Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  1992-09       Impact factor: 4.741

9.  Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRH1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men.

Authors:  G Sassolas; P Chatelain; R Cohen; J P Boissel; S Laporte; J Galleyrand; B Claustrat; A Elmcharfi; J A Chayvialle; H Cohen
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

10.  Uptake and ultrastructural localization of a [125I] growth hormone releasing factor agonist in male rat pituitary gland: evidence for internalization.

Authors:  G Morel
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

View more
  4 in total

1.  Detection of genes expressed in primary colon cancers by in situ hybridisation: overexpression of RACK 1.

Authors:  A Saito; G Fujii; Y Sato; M Gotoh; M Sakamoto; G Toda; S Hirohashi
Journal:  Mol Pathol       Date:  2002-02

2.  Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.

Authors:  Ikuo Kobayashi; Hidehiro Oka; Heiji Naritaka; Yuichi Sato; Kiyotaka Fujii; Toru Kameya
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

3.  Absence of immunostaining for growth hormone in a subset of patients with acromegaly.

Authors:  Jason L Schroeder; Alejandro M Spiotta; Maria Fleseriu; Richard A Prayson; Amir H Hamrahian; Robert J Weil
Journal:  Pituitary       Date:  2014-04       Impact factor: 4.107

4.  Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

Authors:  Raul M Luque; Beatriz S Soares; Xiao-ding Peng; Sonia Krishnan; Jose Cordoba-Chacon; Lawrence A Frohman; Rhonda D Kineman
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.